---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-051663"
form_type: "8-K"
ticker: "ELDN"
cik: "0001404281"
company_name: "Eledon Pharmaceuticals, Inc."
filed_at: "2025-04-07T23:59:59+00:00"
generated_at: "2026-05-23T19:33:00.508271+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Eledon Pharmaceuticals dismisses Crowe LLP, appoints Deloitte as auditor

## Summary
- Audit Committee dismissed Crowe LLP as independent auditor effective April 1, 2025.
- No disagreements or reportable events in fiscal years 2023 and 2024 or interim period.
- Crowe's audit reports for 2023 and 2024 were unqualified and not modified.
- Deloitte & Touche LLP appointed as new auditor for fiscal year ending Dec 31, 2025.

## SEC filing metadata
- accession: 0000950170-25-051663
- form_type: 8-K
- ticker: ELDN
- cik: 0001404281
- company_name: Eledon Pharmaceuticals, Inc.
- filed_at: 2025-04-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1404281/000095017025051663/0000950170-25-051663-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1404281/000095017025051663/eldn-20250401.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-051663
- JSON: https://secwatch.observer/filing/0000950170-25-051663.json
- Plain text: https://secwatch.observer/filing/0000950170-25-051663.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.